DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Tokyo Big Sight

2018 年 11 月 11 日 9:30 上午 - 2018 年 11 月 13 日 5:40 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V2-S6] Efforts to Raise Drug Literacy - How Should We Take Care It in Citizens Themselves Learn about Drugs - (Part 2)

Session Chair(s)

Tomiko  Tawaragi

Tomiko Tawaragi

Director

RAD-AR Council, Japan

Junichi  Nishino, MSc, RPh

Junichi Nishino, MSc, RPh

Head, Regulatory Affairs Department

Otsuka Pharmaceutical Co., Ltd., Japan

“The citizen must strive to deepen knowledge and understanding on the effectiveness and safety of these products as well as properly using medicines and the like” in the Pharmaceuticals and Medical Devices Law. Because of the spread of the Internet, information is flooded, but is it all reliable information? Is it possible to say that the information from the patient’s point of view is now enough prepared? The information that the patient sought is diverse and it is recommended to consult a doctor / pharmacist first, but in addition to that, highly reliable information that the patient themselves can obtain is also necessary. In this session, experts from industry, government and academia will discuss the future directions of drug information provision in Japan on each side of those who prepare and provide drug information, patients, people who explain to patients, and PMDA.

Speaker(s)

Mayumi  Mochizuki, PhD

Can You Imagine the Drug Information will be in Five Years? - Proper Use of Drugs in Revolution -

Mayumi Mochizuki, PhD

Keio University, Japan

Professor Emeritus

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。